Drug Profile
Interferon alpha biosimilar - Afrivax
Latest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator AfriVax
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Hepatitis B